Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03144128 · ClinicalTrials.gov registry record · NA
Vitamin D for Muscle Metabolic Function in Cancer Cachexia
A NA study of Vitamin D Deficiency and Cancer Cachexia, sponsored by David Travis Thomas.
- Completed
- Registry status
- NA
- Development phase
- 1
- Enrollment target
- 1
- Study location
NCT03144128: Completed NA study of Vitamin D Deficiency and Cancer Cachexia, sponsored by David Travis Thomas.
NCT03144128 is a NA study of Vitamin D Deficiency and Cancer Cachexia that has completed, run by David Travis Thomas. The registered enrollment target is 1 participants, below the 276-participant average among 48 other Vitamin D Deficiency trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03144128, a NA study of Vitamin D Deficiency and Cancer Cachexia, has completed, sponsored by David Travis Thomas.
- COMPLETED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed study is aimed at examining mitochondrial function as a potential target of action of vitamin D on muscle metabolism, size, and strength in preventing the progression of cachexia. This is the first clinical trial designed to understand the effects of vitamin D on muscle metabolic dynamics driving dysfunction in cachectic muscle. Our preliminary data suggest that vitamin D promotes lipid partitioning and muscle metabolic function, which the investigators hypothesize, will mitigate cachexia via improved muscle health and quality that translates into reduced fatigue, and improved patient resilience to multimodal cancer therapy.
Primary Outcome
MRI/MRS
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Vitamin D
Study Locations (1)
Kentucky
- Markey Cancer Center - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2018-05-23 |
| Est. Completion | 2018-09-13 |
| Phase | NA |
What the finished NCT03144128 record still lists
NCT03144128 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 276-participant average among 48 other Vitamin D Deficiency trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with Vitamin D Deficiency appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT03144128 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT03144128 about?
NCT03144128 is a clinical study titled "Vitamin D for Muscle Metabolic Function in Cancer Cachexia". The proposed study is aimed at examining mitochondrial function as a potential target of action of vitamin D on muscle metabolism, size, and strength in preventing the progression of cachexia. This is the first clinical trial designed to understand the effects of vitamin D on muscle metabolic dynami...
What is the current status of trial NCT03144128?
This trial is currently completed. It is a NA study. The enrollment target is 1 participants. The study started on 2018-05-23. Estimated completion is 2018-09-13.
What conditions does trial NCT03144128 study?
This clinical trial studies the following conditions: Vitamin D Deficiency, Cancer Cachexia.
What interventions are being tested in trial NCT03144128?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Vitamin D (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03144128?
This trial is sponsored by David Travis Thomas, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03144128 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vitamin D Deficiency
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03144128's enrollment target sits among peer trials
1 49th of 48 the lowest of 48 other Vitamin D Deficiency trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Vitamin D Deficiency trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Randomized Trial of Enteral Vitamin D Supplementation in Infants < 28 Weeks Gestational Age or <1000 Grams Birth Weight
RECRUITING · NA
-
Evaluation of the Clinical and Psychological Impact of Vitamin D Replacement in Adolescent Females at Risk for Polycystic Ovarian Syndrome (PCOS)
RECRUITING · NA
-
ViDES Trial (Vitamin D Extra Supplementation)
ACTIVE NOT RECRUITING · NA
-
Vitamin D Sulfates in Breastmilk
ACTIVE NOT RECRUITING · NA
-
Vitamin D and Adipose Tissue Inflammation
COMPLETED · NA
-
Vitamin D Levels and Vitamin D Education in Geriatric Patients
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI